A young student’s research explored existing medicines for Alzheimer’s disease protection. He identified two drugs, nintedanib and pirfenidone, showing protective effects in cell models. This drug repurposing approach offers a faster, less expensive research starting point. Wang’s work highlights targeting APOE4 and brain blood vessel cell changes. His findings suggest further investigation into TGFβ pathway drugs is warranted.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.